Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women

被引:48
作者
Barcaite, E [1 ]
Bartusevicius, A [1 ]
Railaite, DR [1 ]
Nadisauskiene, R [1 ]
机构
[1] Kaunas Univ Med, Dept Obstet & Gynecol, LT-50009 Kaunas, Lithuania
关键词
misoprostol; cervical ripening; hysteroscopy;
D O I
10.1016/j.ijgo.2005.06.019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effectiveness and possible adverse effects of vaginal. misoprostol. for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Methods: A total of 105 women scheduled for hysteroscopy were randomly assigned to 2 groups. The study group (n=51) received 400 mu g of vaginal. misoprostol at [east 12 h before the procedure and the control group (n = 54) received no cervical priming agent. The primary outcome measure was the number of women who required cervical dilation. Secondary outcomes were cervical width (the largest size of Hegar dilator inserted without resistance) as well as complications and adverse effects. Results: In the misoprostol. group 27 women (52.9%) required cervical dilation vs. 53 (98.1 %) in the control group ( P <0.0001). The largest size of Hegar dilator inserted without resistance was 7.6 +/- 1.4 mm in the misoprostol group vs. 5.0 +/- 1.1 mm in the control group (P<0.0001). A similar effect of misoprostol. on cervical dilation was also found in the subgroup of treated postmenopausal women. Only 2 women (3.9%) experienced mild tower abdominal pain after misoprostol application. Conclusion: Vaginal. misoprostol applied before hysteroscopy reduced cervical resistance and the need for cervical dilation in perimenopausal. and postmenopausal women, with only mild adverse effects. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 23 条
[1]  
[Anonymous], 2005, INTERNET DRUG INDEX
[2]   Complications in hysteroscopy: prevention, treatment and legal risk [J].
Bradley, LD .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2002, 14 (04) :409-415
[3]   Vaginal misoprostol enhances intrauterine insemination [J].
Brown, SE ;
Toner, JP ;
Schnorr, JA ;
Williams, SC ;
Gibbons, WE ;
de Ziegler, D ;
Oehninger, S .
HUMAN REPRODUCTION, 2001, 16 (01) :96-101
[4]   Vaginal misoprostol for cervical priming before dilatation and curettage in postmenopausal women: A randomized controlled trial [J].
Bunnasathiansri, S ;
Herabutya, Y ;
O-Prasertsawat, P .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2004, 30 (03) :221-225
[5]   Misoprostol: A quarter century of use, abuse, and creative misuse [J].
Chong, YS ;
Su, LL ;
Arulkumaran, S .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2004, 59 (02) :128-140
[6]   MISOPROSTOL - DISCOVERY, DEVELOPMENT, AND CLINICAL-APPLICATIONS [J].
COLLINS, PW .
MEDICINAL RESEARCH REVIEWS, 1990, 10 (02) :149-172
[7]   Cervical priming prior to operative hysteroscopy: a randomized comparison of laminaria versus misoprostol [J].
Darwish, AM ;
Ahmad, AM ;
Mohammad, AM .
HUMAN REPRODUCTION, 2004, 19 (10) :2391-2394
[8]   Vaginal misoprostol for cervical ripening before operative hysteroscopy in pre-menopausal women: a double-blind, placebo-controlled trial with three dose regimens [J].
Fernandez, H ;
Alby, JD ;
Tournoux, C ;
Chauveaud-Lambling, A ;
de Tayrac, R ;
Frydman, R ;
Porcher, R .
HUMAN REPRODUCTION, 2004, 19 (07) :1618-1621
[9]   A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women [J].
Fung, TM ;
Lam, MH ;
Wong, SF ;
Ho, LC .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (05) :561-565
[10]   PROSTAGLANDIN VAGINAL SUPPOSITORIES IN NON PREGNANT-WOMEN REQUIRING CERVICAL DILATATION PRIOR TO HYSTEROSCOPY [J].
HALD, F ;
KRISTOFFERSEN, SE ;
GREGERSEN, E .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (03) :219-222